HP-Betadex Solution can be combined with different molecules in the treatment of nasal disorders. A significant percentage of patient suffered from nasal diseases remains uncontrolled despite adequate treatment, and surely in Allergic Rhinitis.
Allergic Rhinitis and its Impact on Asthma (ARIA) tries to gives an international consensus to treat patients suffering from AR, INCS being considered as the first-line treatment.
The INCS cover all AR symptoms that are Nasal congestion/obstruction, rhinorrhoea, itchy nose and/or eyes, and/or sneezing are the symptoms of AR. The overall clinical response does not appear to vary significantly between available INCS, irrespective of the differences in topical potency, lipid solubility, and binding affinity. When givin in recommended doses INCS are not associated with clinically significant systemic side effects.
Because Intranasal corticosteroids are the most effective medication class in controlling the symptoms of allergic rhinitis, Aquilon Pharma’s AQ001N is the key.